Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MI › DOWAGIAC › ASCENSION BORGESS LEE HOSPITAL

ASCENSION BORGESS LEE HOSPITAL

NPI: 1194771030 · DOWAGIAC, MI 49047 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 05/25/2006

$6.88M
Total Medicaid Paid
168,234
Total Claims
145,024
Beneficiaries
128
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHOUGHTON, MARINA (CFO)
NPI Enumeration Date05/25/2006

Related Entities

Other providers sharing the same authorized official: HOUGHTON, MARINA

ProviderCityStateTotal Paid
ASCENSION BORGESS HOSPITAL KALAMAZOO MI $43.08M
ASCENSION MEDICAL GROUP PROMED KALAMAZOO MI $10.60M
ASCENSION MEDICAL GROUP PROMED PORTAGE MI $7.97M
ASCENSION BORGESS ALLEGAN HOSPITAL ALLEGAN MI $6.03M
ASCENSION BORGESS HOSPITAL PLAINWELL MI $4.84M
ASCENSION BORGESS ALLEGAN HOSPITAL ALLEGAN MI $3.71M
ASCENSION BORGESS HOSPITAL PLAINWELL MI $3.71M
ASCENSION BORGESS LEE HOSPITAL DOWAGIAC MI $2.70M
ASCENSION MEDICAL GROUP PROMED KALAMAZOO MI $2.55M
ASCENSION MEDICAL GROUP PROMED PORTAGE MI $2.07M
ASCENSION MEDICAL GROUP PROMED PORTAGE MI $1.64M
ASCENSION BORGESS LEE HOSPITAL DOWAGIAC MI $1.58M
ASCENSION BORGESS HOSPITAL PORTAGE MI $1.22M
ASCENSION BORGESS ALLEGAN HOSPITAL GOBLES MI $298K
ASCENSION BORGESS ALLEGAN HOSPITAL OTSEGO MI $294K
ASCENSION BORGESS ALLEGAN HOSPITAL FENNVILLE MI $246K
ASCENSION BORGESS HOSPITAL KALAMAZOO MI $91K
ASCENSION BORGESS ALLEGAN HOSPITAL ALLEGAN MI $55K
ASCENSION BORGESS ALLEGAN HOSPITAL ALLEGAN MI $43K
ASCENSION BORGESS HOSPITAL KALAMAZOO MI $40K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 30,194 $854K
2019 26,848 $789K
2020 21,882 $935K
2021 27,326 $1.22M
2022 22,513 $1.04M
2023 25,438 $1.18M
2024 14,033 $861K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 11,827 11,255 $1.89M
99284 6,366 6,009 $1.43M
99285 3,623 3,425 $1.33M
96374 3,834 3,546 $449K
99282 2,778 2,718 $251K
74177 1,912 1,016 $232K
97110 6,206 1,621 $178K
96361 2,749 2,504 $109K
71046 4,032 2,095 $102K
74176 1,028 545 $95K
87635 2,649 2,568 $93K
70450 1,278 680 $73K
71045 2,850 1,511 $69K
96375 2,045 1,714 $66K
80053 11,975 10,826 $35K
84443 4,394 4,232 $34K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 682 670 $33K
93005 3,560 3,234 $26K
85025 13,008 11,548 $25K
82306 1,608 1,554 $22K
97161 398 391 $21K
77067 511 263 $20K
80061 2,014 2,001 $19K
72100 744 439 $18K
93010 3,775 3,323 $17K
87651 1,481 1,452 $15K
87491 1,130 1,090 $15K
87591 1,130 1,090 $15K
83036 2,866 2,780 $14K
96360 122 118 $14K
82465 1,375 1,349 $10K
99291 26 24 $10K
G0378 Hospital observation service, per hour 12 12 $8K
36415 9,004 8,274 $7K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 513 505 $7K
73630 673 361 $7K
77063 379 193 $6K
96372 2,920 2,501 $6K
82947 330 235 $6K
96365 58 49 $6K
73562 362 190 $6K
83718 1,362 1,347 $5K
83880 695 658 $5K
87633 21 20 $5K
87086 1,844 1,760 $5K
84478 1,398 1,376 $4K
99281 99 98 $4K
82607 611 585 $4K
73610 504 264 $4K
80307 1,442 1,379 $4K
73130 498 257 $4K
73030 283 149 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,026 924 $3K
84439 617 598 $3K
97140 173 81 $2K
80048 1,664 1,498 $2K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,540 1,520 $2K
83690 2,354 2,181 $2K
99214 51 40 $2K
93975 25 13 $2K
76705 49 26 $2K
76856 63 38 $2K
74018 158 86 $2K
87186 657 603 $2K
85610 1,747 1,509 $1K
81001 3,767 3,567 $936.41
73110 61 27 $893.72
83735 1,107 975 $865.66
87798 33 31 $763.54
84481 87 86 $555.06
85027 197 190 $547.58
87880 536 521 $531.50
82550 271 265 $475.94
90471 35 32 $451.77
87581 21 20 $450.99
87486 21 20 $450.99
94640 648 453 $449.09
81003 2,115 2,059 $445.11
72070 26 16 $442.28
84484 1,908 1,601 $438.39
81025 3,057 2,918 $385.34
G0103 Prostate cancer screening; prostate specific antigen test (psa) 39 38 $368.82
87804 1,387 892 $336.14
85730 1,065 1,012 $320.95
82728 38 38 $243.21
87077 97 88 $227.73
J0696 Injection, ceftriaxone sodium, per 250 mg 358 331 $154.69
87661 15 14 $138.80
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,748 1,703 $136.88
87502 131 130 $126.18
J7030 Infusion, normal saline solution , 1000 cc 3,053 2,701 $115.20
83540 40 38 $113.74
83605 457 398 $76.07
81002 34 33 $74.36
84702 25 24 $66.22
85652 52 50 $53.43
86140 29 25 $53.20
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 782 610 $52.59
87070 27 27 $49.16
82043 12 12 $40.77
85379 117 113 $40.70
J1885 Injection, ketorolac tromethamine, per 15 mg 3,015 2,861 $40.27
87634 119 118 $31.80
87088 16 15 $30.15
86431 12 12 $23.10
87040 58 39 $22.32
86038 12 12 $17.75
80143 64 60 $15.44
80179 64 60 $15.44
87807 75 75 $6.51
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,515 2,263 $1.94
J1170 Injection, hydromorphone, up to 4 mg 193 173 $1.67
J7120 Ringers lactate infusion, up to 1000 cc 162 151 $1.34
J1200 Injection, diphenhydramine hcl, up to 50 mg 128 105 $0.85
J2270 Injection, morphine sulfate, up to 10 mg 171 156 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 12 12 $0.00
C9113 Injection, pantoprazole sodium, per vial 33 28 $0.00
87254 227 141 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 16 15 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 16 15 $0.00
J2704 Injection, propofol, 10 mg 97 91 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 399 375 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 73 68 $0.00
96376 67 47 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 122 97 $0.00
87280 16 16 $0.00
J2060 Injection, lorazepam, 2 mg 33 28 $0.00
J7050 Infusion, normal saline solution, 250 cc 15 12 $0.00